|
|
|
Volumn 91, Issue 12 Suppl, 2006, Pages
|
|
Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DAUNORUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
ONCOPROTEIN;
PLZF RARALPHA FUSION PROTEIN, HUMAN;
PLZF-RARALPHA FUSION PROTEIN, HUMAN;
RETINOIC ACID;
TUMOR MARKER;
TUMOR PROTEIN;
AGED;
ARTICLE;
BONE MARROW;
CASE REPORT;
CHEMISTRY;
CHROMOSOME 15;
CHROMOSOME 17;
COMPUTER SYSTEM;
GENE TRANSLOCATION;
GENETICS;
HUMAN;
PATHOLOGY;
PROMYELOCYTIC LEUKEMIA;
REMISSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
ULTRASTRUCTURE;
6-MERCAPTOPURINE;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW;
CHROMOSOMES, HUMAN, PAIR 15;
CHROMOSOMES, HUMAN, PAIR 17;
COMPUTER SYSTEMS;
DAUNORUBICIN;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
METHOTREXATE;
NEOPLASM PROTEINS;
ONCOGENE PROTEINS, FUSION;
REMISSION INDUCTION;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
TRANSLOCATION, GENETIC;
TRETINOIN;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 37749002473
PISSN: None
EISSN: 15928721
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
